• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

入院时锌水平低与 SARS-CoV-2 感染的临床预后不良相关。

Low Zinc Levels at Admission Associates with Poor Clinical Outcomes in SARS-CoV-2 Infection.

机构信息

Laboratory of Molecular Physiology, Department of Experimental and Health Sciences, Universitat Pompeu Fabra, 08003 Barcelona, Spain.

Molecular Virology Group, Department of Experimental and Health Sciences, Universitat Pompeu Fabra, 08003 Barcelona, Spain.

出版信息

Nutrients. 2021 Feb 9;13(2):562. doi: 10.3390/nu13020562.

DOI:10.3390/nu13020562
PMID:33572045
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7914437/
Abstract

BACKGROUND

Zinc is an essential micronutrient that impacts host-pathogen interplay at infection. Zinc balances immune responses, and also has a proven direct antiviral action against some viruses. Importantly, zinc deficiency (ZD) is a common condition in elderly and individuals with chronic diseases, two groups with an increased risk for severe severe coronavirus disease 2019 (COVID-19) outcomes. We hypothesize that serum zinc content (SZC) influences COVID-19 disease progression, and thus might represent a useful biomarker.

METHODS

We ran an observational cohort study with 249 COVID-19 patients admitted in Hospital del Mar. We have studied COVID-19 severity and progression attending to SZC at admission. In parallel, we have studied severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) replication in the Vero E6 cell line modifying zinc concentrations.

FINDINGS

Our study demonstrates a correlation between serum zinc levels and COVID-19 outcome. Serum zinc levels lower than 50 µg/dL at admission correlated with worse clinical presentation, longer time to reach stability, and higher mortality. Our in vitro results indicate that low zinc levels favor viral expansion in SARS-CoV-2 infected cells.

INTERPRETATION

Low SZC is a risk factor that determines COVID-19 outcome. We encourage performing randomized clinical trials to study zinc supplementation as potential prophylaxis and treatment with people at risk of zinc deficiency.

摘要

背景

锌是一种必需的微量元素,它会影响感染过程中的宿主-病原体相互作用。锌平衡免疫反应,并且对某些病毒具有已被证实的直接抗病毒作用。重要的是,锌缺乏症(ZD)是老年人和患有慢性疾病的个体的常见病症,这两个群体患严重的 2019 年冠状病毒病(COVID-19)的风险增加。我们假设血清锌含量(SZC)会影响 COVID-19 的疾病进展,因此可能是一个有用的生物标志物。

方法

我们对在巴塞罗那港医院住院的 249 名 COVID-19 患者进行了一项观察性队列研究。我们研究了入院时 SZC 对 COVID-19 严重程度和进展的影响。同时,我们通过改变锌浓度,在 Vero E6 细胞系中研究了严重急性呼吸系统综合征冠状病毒 2(SARS-CoV2)的复制。

发现

我们的研究表明血清锌水平与 COVID-19 结局之间存在相关性。入院时血清锌水平低于 50μg/dL 与更严重的临床表现、达到稳定状态的时间更长和更高的死亡率相关。我们的体外结果表明,低锌水平有利于 SARS-CoV-2 感染细胞中的病毒扩增。

解释

低 SZC 是决定 COVID-19 结局的危险因素。我们鼓励进行随机临床试验,以研究锌补充作为潜在的预防和治疗锌缺乏症高危人群的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cad/7914437/586a7518118e/nutrients-13-00562-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cad/7914437/823f14245ad4/nutrients-13-00562-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cad/7914437/9e80006cc81c/nutrients-13-00562-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cad/7914437/586a7518118e/nutrients-13-00562-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cad/7914437/823f14245ad4/nutrients-13-00562-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cad/7914437/9e80006cc81c/nutrients-13-00562-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cad/7914437/586a7518118e/nutrients-13-00562-g003.jpg

相似文献

1
Low Zinc Levels at Admission Associates with Poor Clinical Outcomes in SARS-CoV-2 Infection.入院时锌水平低与 SARS-CoV-2 感染的临床预后不良相关。
Nutrients. 2021 Feb 9;13(2):562. doi: 10.3390/nu13020562.
2
Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.I型、II型和III型干扰素的抗病毒活性可抵消ACE2的诱导性并限制新型冠状病毒。
mBio. 2020 Sep 10;11(5):e01928-20. doi: 10.1128/mBio.01928-20.
3
Cysteamine with In Vitro Antiviral Activity and Immunomodulatory Effects Has the Potential to Be a Repurposing Drug Candidate for COVID-19 Therapy.具有体外抗病毒活性和免疫调节作用的半胱胺有可能成为治疗 COVID-19 的重新定位药物候选物。
Cells. 2021 Dec 24;11(1):52. doi: 10.3390/cells11010052.
4
Human Nasal and Lung Tissues Infected with SARS-CoV-2 Provide Insights into Differential Tissue-Specific and Virus-Specific Innate Immune Responses in the Upper and Lower Respiratory Tract.人鼻腔和肺部组织感染 SARS-CoV-2 提供了在上呼吸道和下呼吸道中不同组织特异性和病毒特异性先天免疫反应的见解。
J Virol. 2021 Jun 24;95(14):e0013021. doi: 10.1128/JVI.00130-21.
5
Course and Survival of COVID-19 Patients with Comorbidities in Relation to the Trace Element Status at Hospital Admission.COVID-19 患者合并症的病程和生存与入院时微量元素状况的关系。
Nutrients. 2021 Sep 22;13(10):3304. doi: 10.3390/nu13103304.
6
Association Between Low Zinc Levels and Severity of Acute Respiratory Distress Syndrome by New Coronavirus SARS-CoV-2.新型冠状病毒SARS-CoV-2导致的低锌水平与急性呼吸窘迫综合征严重程度之间的关联
Nutr Clin Pract. 2021 Feb;36(1):186-191. doi: 10.1002/ncp.10612. Epub 2020 Dec 23.
7
Hypozincemia in COVID-19 Patients Correlates With Stronger Antibody Response.COVID-19 患者低血锌与更强的抗体反应相关。
Front Immunol. 2022 Jan 4;12:785599. doi: 10.3389/fimmu.2021.785599. eCollection 2021.
8
Plasma zinc status and hyperinflammatory syndrome in hospitalized COVID-19 patients: An observational study.住院 COVID-19 患者的血浆锌状态与高炎症综合征:一项观察性研究。
Int Immunopharmacol. 2021 Nov;100:108163. doi: 10.1016/j.intimp.2021.108163. Epub 2021 Sep 20.
9
Identification of Common Deletions in the Spike Protein of Severe Acute Respiratory Syndrome Coronavirus 2.鉴定严重急性呼吸综合征冠状病毒 2 的刺突蛋白中的常见缺失。
J Virol. 2020 Aug 17;94(17). doi: 10.1128/JVI.00790-20.
10
Evaluation of in vitro activity of copper gluconate against SARS-CoV-2 using confocal microscopy-based high content screening.利用基于共聚焦显微镜的高通量筛选技术评估葡萄糖酸铜对 SARS-CoV-2 的体外活性。
J Trace Elem Med Biol. 2021 Dec;68:126818. doi: 10.1016/j.jtemb.2021.126818. Epub 2021 Jul 8.

引用本文的文献

1
Zinc deficiency as possible link between immunosenescence and age-related diseases.锌缺乏可能是免疫衰老与年龄相关疾病之间的联系。
Immun Ageing. 2025 May 19;22(1):19. doi: 10.1186/s12979-025-00511-1.
2
Genomic prediction and QTL analysis for grain Zn content and yield in -derived rice populations.衍生水稻群体中籽粒锌含量和产量的基因组预测与QTL分析。
J Plant Biochem Biotechnol. 2024;33(2):216-236. doi: 10.1007/s13562-024-00886-0. Epub 2024 May 9.
3
Association of zinc deficiency and clinical symptoms, inflammatory markers, severity of COVID-19 in hospitalized children.

本文引用的文献

1
Prediction of survival odds in COVID-19 by zinc, age and selenoprotein P as composite biomarker.用锌、年龄和硒蛋白 P 作为复合生物标志物预测 COVID-19 的生存几率。
Redox Biol. 2021 Jan;38:101764. doi: 10.1016/j.redox.2020.101764. Epub 2020 Oct 20.
2
COVID-19 outpatients: early risk-stratified treatment with zinc plus low-dose hydroxychloroquine and azithromycin: a retrospective case series study.COVID-19 门诊患者:锌联合小剂量羟氯喹和阿奇霉素的早期风险分层治疗:一项回顾性病例系列研究。
Int J Antimicrob Agents. 2020 Dec;56(6):106214. doi: 10.1016/j.ijantimicag.2020.106214. Epub 2020 Oct 26.
3
Zinc sulfate in combination with a zinc ionophore may improve outcomes in hospitalized COVID-19 patients.
住院儿童锌缺乏与临床症状、炎症标志物、新冠病毒疾病严重程度的关联
Front Nutr. 2025 Mar 25;12:1566505. doi: 10.3389/fnut.2025.1566505. eCollection 2025.
4
Associations Between Dietary Patterns and the Occurrence of Hospitalization and Gastrointestinal Disorders-A Retrospective Study of COVID-19 Patients.饮食模式与住院及胃肠道疾病发生之间的关联——一项针对COVID-19患者的回顾性研究
Nutrients. 2025 Feb 26;17(5):800. doi: 10.3390/nu17050800.
5
Zinc Deficiency Associated With an Increase in Mortality in COVID-19 Patients: A Meta-Analysis.锌缺乏与新冠病毒肺炎患者死亡率增加相关:一项荟萃分析
Cureus. 2025 Jan 6;17(1):e77011. doi: 10.7759/cureus.77011. eCollection 2025 Jan.
6
Association Between Serum Zinc Concentration Levels And Severity Of Coronavirus Disease 2019 (Covid-19) In Japanese Inpatients.日本住院患者血清锌浓度水平与2019冠状病毒病(COVID-19)严重程度之间的关联
Int J Gen Med. 2024 Oct 16;17:4745-4753. doi: 10.2147/IJGM.S476578. eCollection 2024.
7
The nutritional roles of zinc for immune system and COVID-19 patients.锌对免疫系统及新冠患者的营养作用。
Front Nutr. 2024 Apr 19;11:1385591. doi: 10.3389/fnut.2024.1385591. eCollection 2024.
8
Coordination chemistry suggests that independently observed benefits of metformin and Zn against COVID-19 are not independent.配位化学表明,二甲双胍和锌对新冠病毒独立观察到的益处并非相互独立。
Biometals. 2024 Aug;37(4):983-1022. doi: 10.1007/s10534-024-00590-5. Epub 2024 Apr 5.
9
Dietary mineral intakes predict Coronavirus-disease 2019 (COVID-19) incidence and hospitalization in older adults.膳食矿物质摄入量可预测老年人感染2019冠状病毒病(COVID-19)的发病率和住院率。
BMC Nutr. 2024 Mar 4;10(1):42. doi: 10.1186/s40795-024-00821-5.
10
Zinc Deficiency And sTNF-RII Are Associated With Worse COVID-19 Outcomes.锌缺乏和可溶性肿瘤坏死因子受体 II 与 COVID-19 不良结局相关。
J Nutr. 2024 May;154(5):1588-1595. doi: 10.1016/j.tjnut.2023.11.026. Epub 2023 Dec 2.
硫酸锌与锌离子载体联合应用可能改善住院 COVID-19 患者的结局。
J Med Microbiol. 2020 Oct;69(10):1228-1234. doi: 10.1099/jmm.0.001250. Epub 2020 Sep 15.
4
COVID-19: Poor outcomes in patients with zinc deficiency.新型冠状病毒肺炎:锌缺乏症患者的不良预后。
Int J Infect Dis. 2020 Nov;100:343-349. doi: 10.1016/j.ijid.2020.09.014. Epub 2020 Sep 10.
5
Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19.羟氯喹或联合阿奇霉素治疗轻中度 COVID-19。
N Engl J Med. 2020 Nov 19;383(21):2041-2052. doi: 10.1056/NEJMoa2019014. Epub 2020 Jul 23.
6
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.羟氯喹作为 COVID-19 暴露后预防的随机试验。
N Engl J Med. 2020 Aug 6;383(6):517-525. doi: 10.1056/NEJMoa2016638. Epub 2020 Jun 3.
7
Does zinc supplementation enhance the clinical efficacy of chloroquine/hydroxychloroquine to win today's battle against COVID-19?补锌能否增强氯喹/羟氯喹的临床疗效,赢得抗击 COVID-19 的今天?
Med Hypotheses. 2020 Sep;142:109815. doi: 10.1016/j.mehy.2020.109815. Epub 2020 May 6.
8
Clinical and immunological features of severe and moderate coronavirus disease 2019.新型冠状病毒病 2019 重症和中度患者的临床和免疫学特征。
J Clin Invest. 2020 May 1;130(5):2620-2629. doi: 10.1172/JCI137244.
9
Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro.羟氯喹啉是氯喹毒性较低的衍生物,在体外可有效抑制严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染。
Cell Discov. 2020 Mar 18;6:16. doi: 10.1038/s41421-020-0156-0. eCollection 2020.
10
In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).羟氯喹治疗严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2)的体外抗病毒活性和优化剂量设计预测。
Clin Infect Dis. 2020 Jul 28;71(15):732-739. doi: 10.1093/cid/ciaa237.